Similar articles for PMID: 24198391

Year	Number of Results
2003	1
2004	4
2006	3
2007	5
2008	3
2009	5
2010	5
2011	12
2012	9
2013	10
2014	14
2015	12
2016	9
2017	4
2018	4
2019	7
2020	7
2021	2
2022	2
2023	4
2024	0

1

A comparative study of radiolabeled bombesin analogs for the PET imaging of prostate cancer.

Liu Y, Hu X, Liu H, Bu L, Ma X, Cheng K, Li J, Tian M, Zhang H, Cheng Z. Liu Y, et al. J Nucl Med. 2013 Dec;54(12):2132-8. doi: 10.2967/jnumed.113.121533. Epub 2013 Nov 6. J Nucl Med. 2013. PMID: 24198391 Free PMC article.

2

Synthesis and biological evaluation of copper-64 radiolabeled [DUPA-6-Ahx-(NODAGA)-5-Ava-BBN(7-14)NH2], a novel bivalent targeting vector having affinity for two distinct biomarkers (GRPr/PSMA) of prostate cancer.

Bandari RP, Jiang Z, Reynolds TS, Bernskoetter NE, Szczodroski AF, Bassuner KJ, Kirkpatrick DL, Rold TL, Sieckman GL, Hoffman TJ, Connors JP, Smith CJ. Bandari RP, et al. Nucl Med Biol. 2014 Apr;41(4):355-63. doi: 10.1016/j.nucmedbio.2014.01.001. Epub 2014 Jan 10. Nucl Med Biol. 2014. PMID: 24508213 Free PMC article.

3

PET Probes for Preclinical Imaging of GRPR-Positive Prostate Cancer: Comparative Preclinical Study of [⁶⁸Ga]Ga-NODAGA-AMBA and [⁴⁴Sc]Sc-NODAGA-AMBA.

Kálmán-Szabó I, Szabó JP, Arató V, Dénes N, Opposits G, Jószai I, Kertész I, Képes Z, Fekete A, Szikra D, Hajdu I, Trencsényi G. Kálmán-Szabó I, et al. Int J Mol Sci. 2022 Sep 2;23(17):10061. doi: 10.3390/ijms231710061. Int J Mol Sci. 2022. PMID: 36077458 Free PMC article.

4

Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.

Richter S, Wuest M, Krieger SS, Rogers BE, Friebe M, Bergmann R, Wuest F. Richter S, et al. Nucl Med Biol. 2013 Nov;40(8):1025-34. doi: 10.1016/j.nucmedbio.2013.07.005. Epub 2013 Aug 19. Nucl Med Biol. 2013. PMID: 23969085

5

In vitro and in vivo evaluation of a (18)F-labeled high affinity NOTA conjugated bombesin antagonist as a PET ligand for GRPR-targeted tumor imaging.

Varasteh Z, Aberg O, Velikyan I, Lindeberg G, Sörensen J, Larhed M, Antoni G, Sandström M, Tolmachev V, Orlova A. Varasteh Z, et al. PLoS One. 2013 Dec 3;8(12):e81932. doi: 10.1371/journal.pone.0081932. eCollection 2013. PLoS One. 2013. PMID: 24312607 Free PMC article.

6

Preclinical Study on GRPR-Targeted (68)Ga-Probes for PET Imaging of Prostate Cancer.

Sun Y, Ma X, Zhang Z, Sun Z, Loft M, Ding B, Liu C, Xu L, Yang M, Jiang Y, Liu J, Xiao Y, Cheng Z, Hong X. Sun Y, et al. Bioconjug Chem. 2016 Aug 17;27(8):1857-64. doi: 10.1021/acs.bioconjchem.6b00279. Epub 2016 Jul 26. Bioconjug Chem. 2016. PMID: 27399868

7

Evaluation of a ⁶⁴Cu‑labeled 1,4,7‑triazacyclononane, 1‑glutaric acid‑4,7 acetic acid (NODAGA)‑galactose‑bombesin analogue as a PET imaging probe in a gastrin‑releasing peptide receptor‑expressing prostate cancer xenograft model.

Kim MH, Park JA, Woo SK, Lee KC, An GI, Kim BS, Kim KI, Lee TS, Kim CW, Kim KM, Kang JH, Lee YJ. Kim MH, et al. Int J Oncol. 2015 Mar;46(3):1159-68. doi: 10.3892/ijo.2015.2832. Epub 2015 Jan 9. Int J Oncol. 2015. PMID: 25586565

8

N-terminal modifications improve the receptor affinity and pharmacokinetics of radiolabeled peptidic gastrin-releasing peptide receptor antagonists: examples of 68Ga- and 64Cu-labeled peptides for PET imaging.

Gourni E, Mansi R, Jamous M, Waser B, Smerling C, Burian A, Buchegger F, Reubi JC, Maecke HR. Gourni E, et al. J Nucl Med. 2014 Oct;55(10):1719-25. doi: 10.2967/jnumed.114.141242. Epub 2014 Aug 21. J Nucl Med. 2014. PMID: 25146125 Free article.

9

Bombesin antagonist-based radioligands for translational nuclear imaging of gastrin-releasing peptide receptor-positive tumors.

Abiraj K, Mansi R, Tamma ML, Fani M, Forrer F, Nicolas G, Cescato R, Reubi JC, Maecke HR. Abiraj K, et al. J Nucl Med. 2011 Dec;52(12):1970-8. doi: 10.2967/jnumed.111.094375. Epub 2011 Nov 11. J Nucl Med. 2011. PMID: 22080443 Free article.

10

Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of human prostate cancer xenografts.

Schroeder RP, van Weerden WM, Krenning EP, Bangma CH, Berndsen S, Grievink-de Ligt CH, Groen HC, Reneman S, de Blois E, Breeman WA, de Jong M. Schroeder RP, et al. Eur J Nucl Med Mol Imaging. 2011 Jul;38(7):1257-66. doi: 10.1007/s00259-011-1775-3. Epub 2011 Mar 23. Eur J Nucl Med Mol Imaging. 2011. PMID: 21431398 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year